RadioVal

International Clinical Validation of Radiomics Artificial Intelligence for Breast Cancer Treatment Planning

OBJECTIVES

Implement the very first international, multi-faceted clinical validation study for radiomics-based prediction of response to neoadjuvant therapy in multiple developed and developing countries.
Introduce a holistic, standardised methodological framework for multi-faceted and trustworthy evaluation of radiomics AI, taking into account multiple technical, clinical as well as ethical criteria.
Develop the very first traceability tool for radiomics AI, which will enable transparent monitoring and continuous evaluation of radiomics tools during their lifetime.
Evaluate wider impacts of clinical deployment of radiomics AI, including associated cost-benefits, socio-ethical implications and regulatory aspects.

ROLES

Coordinate and manage the RadioVal project
Coordinate the outreach activities
Coordinate the evaluation and calibration of the tool
Develop machine learning techniques for reproducible, robust and interpretable decision support in oncology

PARTNERS

NO.	INSTITUTION	COUNTRY
1	University of Barcelona	Spain
2	Universiteit Maastricht	Netherlands
3	Quibim. S.L	Spain
4	Foundation for Research and Technology (FORTH)	Greece
5	Maggioli	Italy
6	Shine 2Europe	Portugal
7	NHG Finland	Finland
8	Fundación para la Investigacion Del Hospital Universitario La Fe De La Communidad Valenciana (HULAFE)	Spain
9	Karolinska Institutet	Sweden
10	Gdanski Uniwersytet Medyczny	Poland
11	University of Zagreb School of Medicine	Croatia
12	Medical University of Vienna	Austria
13	Hacettepe Universitesi	Turkey
14	Alexander Fleming Institute	Argentina
15	Ain Shams University	Egypt
16	European Institute for Biomedical Imaging Research (EIBIR)	Austria